Evofem Biosciences Inc (OTCPK:EVFM)
$ 0.01 0.00004 (0.4%) Market Cap: 1.00 Mil Enterprise Value: 50.34 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 0/100

Q4 2021 Evofem Biosciences Inc Earnings Call Transcript

Mar 03, 2022 / 09:30PM GMT
Release Date Price: $918.75 (-8.12%)
Operator

Thank you for standing by, and welcome to the Evofem Biosciences Fourth Quarter and Year-end 2021 Results Conference Call. (Operator Instructions) As a reminder today's conference call is being recorded.

I would now like to turn the conference over to your host, Ms. Amy Raskopf, Vice President of Investor Relations. Ma'am, you may begin.

Amy Raskopf
Evofem Biosciences, Inc. - VP of IR

Thank you, Valerie. Good afternoon, everyone, and welcome to the Evofem Biosciences Q4 and Year-end 2021 Results Call. If you haven't done so already, I encourage you to access the press release we issued this afternoon and slides accompanying this call, both of which are at evofem.com under the Investors tab.

Before we begin, I would like to remind you that remarks made on this call will contain forward-looking statements, which are made only as of today, March 3, 2022. For a more detailed description of important risk factors that could cause our actual results to differ materially, please refer to our annual report on Form 10-K and our most recently filed 10

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot